Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
15-Year Lipid Profile Effects on Cardiovascular Events Adjusted for Cardiovascular Risk Factors: A Cohort Study From Middle-East Publisher Pubmed



Sadeghi M1 ; Golshahi J2 ; Talaei M3 ; Sheikhbahaei E4 ; Ghodjani E5 ; Mansouri M6 ; Mansouri P7 ; Sarrafzadegan N8 ; Roohafza H8
Authors
Show Affiliations
Authors Affiliations
  1. 1. Cardiac Rehabilitation Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Hypertension Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Institute of Population Health Sciences, Barts and the London School of Medicine, Queen Mary University of London, United Kingdom
  4. 4. Heart Failure Research Center, Cardiovascular Research Institute, Isfahan University of Medical Science, Isfahan, Iran
  5. 5. Pediatric Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
  6. 6. Interventional Cardiology Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
  7. 7. Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran
  8. 8. Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Acta Cardiologica Published:2021


Abstract

Background: Dyslipidaemia is a risk factor for cardiovascular disease (CVD); however, there are only a few long-term cohort studies. The aim of this unique study is to evaluate the effects of several lipid markers on cardiovascular outcomes during a 15-year follow-up from the Isfahan cohort study (ICS). Methods: This ongoing cohort study was started in 2001 in three cities of Iran. The study population includes 5432 individuals older than 35 years and with Iranian citizenship. All of the patients were evaluated every 2 years by telephone and a full medical examination with blood sampling was conducted every 5 years. The data were recorded in our checklists. Dyslipidaemia was defined according to the ATPIII criteria. Our endpoints in this study were any cardiovascular events such as stroke, sudden cardiac death, unstable angina or myocardial infarction (MI). Results: cardiovascular events were significantly higher in males, older people, diabetics, smokers, patients with higher BMIs, higher blood pressure, dyslipidaemia and less educational level, physical activity index and global dietary index. Our adjusted multivariable analysis (for cardiovascular risk factors and demographic factors) revealed that dyslipidaemia could increase the risk of 15-year cardiovascular events by 1.59 times (HR = 1.59 [1.23–2.06], p value <.001) adjusted for demographic factors and baseline cardiovascular risk factors. Conclusions: Dyslipidaemia, as an independent risk factor, was associated with future cardiovascular events. In this regard, serum lipid screening can help to decrease the risk of long-term cardiovascular events. © 2021 Belgian Society of Cardiology.
Other Related Docs
11. Dietary Patterns in Relation to Lipid Profiles Among Iranian Adults, Journal of Cardiovascular and Thoracic Research (2019)
13. Trend of Atherosclerosis Risk Factors in Children of Isfahan, Asian Cardiovascular and Thoracic Annals (2001)
14. Prevalence of Total Cholesterol in Iran: Systematic Review and Meta-Analysis, Journal of Mazandaran University of Medical Sciences (2015)
19. Low-Density Lipoprotein Cholesterol and Metabolic Syndrome in an Iranian High-Risk Population, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2015)
32. Low-Density Lipoprotein Cholesterol and Risk of Type 2 Diabetes: The Isfahan Diabetes Prevention Study, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2018)
36. The Modifiable Noncommunicable Risk Factors Among an Iranian Population, Southeast Asian Journal of Tropical Medicine and Public Health (2012)
39. Metabolic Syndrome and the Risk of Ischemic Stroke, Journal of Stroke and Cerebrovascular Diseases (2017)
40. Risk Factors for Coronary Artery Disease in Isfahan, Iran, European Journal of Public Health (1999)
46. Lipid Profile in Patients With Ischemic and Hemorrhagic Stroke, Journal of Isfahan Medical School (2011)